ChemBio Annouces the Collaboration with FIND Moving to Development of HCV Point-Of-Care Diagnostic-Test

 ChemBio Annouces the Collaboration with FIND Moving to Development of HCV Point-Of-Care Diagnostic-Test

ChemBio Annouces the Collaboration with FIND Moving to Development of HCV Point-Of-Care Diagnostic-Test

Shots:
  • ChemBio will be using its patented DPP® technology platform to test rapid HCV core antigen assay
  • Parallely, FIND is conducting pilot studies in six countries to introduce novel algorithms and demonstrate the impact of HCV rapid diagnostics
  • FIND plans to assess the outcomes of the feasibility studies in Dec’18 and fund one company for further development and validation of the HCV core antigen assay
  • As per WHO, ~71Mn people are suffering from HCV infection with nearly 400,00 deaths/yr

Click here to read full press release/ article | Ref: Chembio Diagnostics | Image: ChemBio

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post